LifeStance Health Group, Inc. LFST
Set alert
13.40 USD -0.23 -1.72%
At close · Oct 30
13.40 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
13.27 Day range 13.76
4.81 52-week range 13.64
- YTD
- +90.34%
- 1 year
- +172.91%
- Open
- 13.69
- Prev close
- 13.64
- Mkt cap
- 5.09B
- Vol
- 2.30M
- Avg vol
- 4.41M
- EPS
- 0.13
- P/E
- 103.08
- Div yield
- 0.00%
More statistics
- Low
- 13.27
- High
- 13.76
- Forward P/E
- 31.11
- Beta
- 1.24
- Short ratio
- 2.99
- Inst. own
- 89.66%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 12.47
- 200-d avg
- 9.31
- 1y target
- 14.45
6M chart
Events in this range
- May 7, 2026Earnings: 0.04; estimate 0.01; surprise 300%
- Aug 6, 2026Earnings: 0.06; estimate 0.03275; surprise 83.21%
- Aug 7, 2026Rating: BTIG · Buy → Buy
- Aug 14, 2026Rating: JP Morgan · Neutral → Neutral
- Aug 19, 2026Rating: BTIG · Buy → Buy
- Sep 9, 2026Rating: Canaccord Genuity · Buy → Buy
- Sep 10, 2026Rating: Barclays · Overweight → Overweight
- Oct 5, 2026Rating: Keybanc · Overweight → Overweight
Signals (23)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Oct 29, 2026 | 2 days ago |
| SMA: Bullish | Oct 22, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 22, 2026 | 1 week ago |
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 16, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 12, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 8, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 1, 2026 | 1 month ago |
| SMA: Bullish | Sep 30, 2026 | 1 month ago |
| SMA: Bearish | Sep 24, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 15, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 14, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 26, 2026 | 2 months ago |
| RSI: Overbought | Aug 19, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 11, 2026 | 2 months ago |
| RSI: Overbought | Jul 16, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 13, 2026 | 3 months ago |
| RSI: Overbought | Jun 22, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 11, 2026 | 4 months ago |
| MACD: Sell Signal | May 18, 2026 | 5 months ago |
| RSI: Overbought | May 7, 2026 | 5 months ago |
Key statistics
- Market cap
- 5.09B
- Enterprise value
- 5.46B
- Trailing P/E
- 103.08
- Forward P/E
- 31.11
- PEG ratio
- 0.00
- Price / sales
- 3.21
- Price / book
- 3.47
- EPS (TTM)
- 0.13
- Beta
- 1.24
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 3.19%
- Revenue (TTM)
- 1.58B
- Revenue growth
- 26.10%
- Free cash flow
- 172.36M
- Total cash
- 225.94M
- Total debt
- 474.15M
- Return on equity
- 3.43%
- Shares outstanding
- 380.15M
- Short % of float
- 7.54%
- 50-day average
- 12.47
- 200-day average
- 9.31
Analyst view
Consensus: buy
Buy
Price target (mean) 14.45 +7.8% upside
Now 13.40
- Target (low)
- 12.00
- Target (mean)
- 14.45
- Target (high)
- 18.00
Ratings (0m) 11 9 buy · 2 hold · 0 sell
- Strong buy2
- Buy7
- Hold2
- Sell0
- Strong sell0
Next earnings
Nov 5, 2026
Expected Nov 5, 2026. Consensus EPS estimate 0.08388.
Financials — quick view
LFST Revenue — quarterly 435.35M
LFST Net income — quarterly 23.61M
LFST EPS — quarterly 0.06
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 5, 2026 | Sep 30, 2026 | 0.03687 | — | — | — |
| Aug 6, 2026 | Jun 30, 2026 | 0.03275 | 0.06 | +0.03 | +83.21% |
| May 7, 2026 | Mar 31, 2026 | 0.01 | 0.04 | +0.03 | +300.00% |
| Feb 25, 2026 | Dec 31, 2025 | -0.00094 | 0.03 | +0.03 | +3,291.49% |
| Nov 6, 2025 | Sep 30, 2025 | -0.01 | 0.00277 | +0.01 | +127.70% |
| Aug 7, 2025 | Jun 30, 2025 | -0.03 | -0.01 | +0.02 | +66.67% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 5, 2026 | Keybanc | main | Overweight | Overweight |
| Sep 10, 2026 | Barclays | main | Overweight | Overweight |
| Sep 9, 2026 | Canaccord Genuity | main | Buy | Buy |
| Aug 19, 2026 | BTIG | main | Buy | Buy |
| Aug 14, 2026 | JP Morgan | main | Neutral | Neutral |
| Aug 7, 2026 | BTIG | main | Buy | Buy |
About LifeStance Health Group, Inc.
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It also treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- lifestance.com
News
- LifeStance Patients With Treatment-Resistant Depression See Clinically Meaningful Improvement in Symptoms After Esketamine or TMS Treatment, New Data Shows
- LifeStance to Host Third Quarter 2026 Earnings Conference Call on November 5, 2026
- Take the Zacks Approach to Beat the Markets: HF Sinclair, Accenture & FirstCash in Focus
- Transcript: LifeStance Health Gr Q2 2026 Earnings Conference Call
- Keybanc Maintains Overweight on LifeStance Health Gr, Raises Price Target to $15
- Nearly Half of Americans Say Fear of an Unwanted Viral Moment Keeps Them from Being Themselves in Public, LifeStance Survey Finds
- LifeStance Health CTO Sells 42,067 Shares for $541,402
- 74,169 Shares in LifeStance Health Group, Inc. $LFST Bought by HighTower Advisors LLC
- LifeStance Health Group, Inc. (LFST) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
- Analyzing Mangoceuticals (NASDAQ:MGRX) and LifeStance Health Group (NASDAQ:LFST)
Your note
Sign in to keep a note on LFST — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BESSLER ROBERT | Director | Stock Award(Grant) | Jul 1, 2026 | 1,308,050 |
| BLACK DARREN M | Director | Sale | May 11, 2026 | 0 |
| BOURDON DAVID | Chief Executive Officer | Stock Award(Grant) | Mar 8, 2026 | 1,398,250 |
| BURDICK KENNETH A | Director | Sale | Aug 10, 2026 | 3,017,320 |
| PANTALEONI PABLO | Officer | Sale | Mar 9, 2025 | 0 |
| PARDO RYAN | Officer and Director | Stock Award(Grant) | Mar 8, 2026 | 3,654,260 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| TPG GP A, LLC | 29.24% | 111,744,614 | 1.50B | Jun 29, 2026 |
| FMR, LLC | 15.24% | 58,252,466 | 780.58M | Jun 29, 2026 |
| Blackrock Inc. | 9.51% | 36,348,507 | 487.07M | Jun 29, 2026 |
| Summit Partners, L.P. | 4.35% | 16,623,824 | 222.76M | Sep 29, 2026 |
| Vanguard Portfolio Management LLC | 3.65% | 13,960,892 | 187.08M | Jun 29, 2026 |
| Jennison Associates LLC | 3.16% | 12,077,557 | 161.84M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 4.21% | 16,071,660 | 215.36M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.76% | 6,740,311 | 90.32M | Jun 29, 2026 |
| Fidelity Securities Fund-Fidelity Small Cap Value Fund | 1.71% | 6,520,537 | 87.38M | Jul 30, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 1.69% | 6,465,187 | 86.63M | Sep 29, 2026 |
| Variable Insurance Products Fund II-VIP Contrafund Portfolio | 1.55% | 5,911,337 | 79.21M | Aug 30, 2026 |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 1.42% | 5,442,419 | 72.93M | Jul 30, 2026 |